6533b857fe1ef96bd12b4639
RESEARCH PRODUCT
Lack of neurofibromatosis type 2 gene promoter methylation in sporadic vestibular schwannomas.
Wolf J. MannG RuerupJürgen BriegerDimitrios Koutsimpelassubject
AdultMaleBiologymedicine.disease_causePolymerase Chain Reactionchemistry.chemical_compoundYoung Adultotorhinolaryngologic diseasesmedicineHumansNeurofibromatosis type 2NeurofibromatosisGeneAgedRetrospective StudiesMutationNeurofibromin 2PromoterMethylationDNA NeoplasmNeuroma AcousticDNA MethylationMiddle Agedmedicine.diseaseOtorhinolaryngologychemistryDNA methylationMutationCancer researchDisease ProgressionFemaleDNAFollow-Up Studiesdescription
<i>Background:</i> Vestibular schwannomas (VS) are benign tumors of the nervous system that are usually sporadic but also occur in the inherited disorder neurofibromatosis type 2 (NF2). In VS, losses of chromosomal material and mutations of the NF2 gene have been established to be causative. For a subset of VS without detectable gene alterations, promoter inactivation by hypermethylation has been suggested. However, published data are very limited and contradictory. <i>Methods:</i> We analyzed NF2 gene promoter methylation in 35 sporadic VS by methylation-specific PCR. <i>Results:</i> Twenty-three of the tumors were informative, showing no promoter methylation. In the remaining 12 tumors, promoter methylation could neither be verified nor excluded. <i>Conclusions:</i> Our study suggests that NF2 gene inactivation by promoter hypermethylation is a rare or very uncommon mechanism of NF2 gene inactivation in sporadic VS. Other mechanisms destabilizing the NF2 gene product, yet to be identified, might play a role in the genesis of VS apart from the loss or mutation of the NF2 gene.
year | journal | country | edition | language |
---|---|---|---|---|
2011-09-14 | ORL; journal for oto-rhino-laryngology and its related specialties |